CCHFVACIM | Crimean-Congo Haemorrhagic Fever Vaccine and Immunotherapy 01-01-2024 - 31-12-2027 Show more information EU-Programme-Call Horizon Europe HORIZON.2 Global Challenges and European Industrial Competitiveness HORIZON.2.1 Health HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine HORIZON-HLTH-2023-DISEASE-03 HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
FLAVIVACCINE | Development and characterization of a pan-flavivirus vaccine candidate 01-01-2024 - 31-12-2027 Show more information EU-Programme-Call Horizon Europe HORIZON.2 Global Challenges and European Industrial Competitiveness HORIZON.2.1 Health HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine HORIZON-HLTH-2023-DISEASE-03 HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
LWNVIVAT | Limiting West Nile Virus impact by novel vaccines and therapeutics approaches 01-12-2023 - 30-11-2027 Show more information EU-Programme-Call Horizon Europe HORIZON.2 Global Challenges and European Industrial Competitiveness HORIZON.2.1 Health HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine HORIZON-HLTH-2023-DISEASE-03 HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
VICI-DISEASE | PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AND CLINICAL TESTING OF A NOVEL CAPSID VIRUS LIKE PARTICLE (CVLP) VACCINE 01-12-2023 - 30-11-2027 Show more information EU-Programme-Call Horizon Europe HORIZON.2 Global Challenges and European Industrial Competitiveness HORIZON.2.1 Health HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine HORIZON-HLTH-2023-DISEASE-03 HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
MARVAX | Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reactive protection 01-12-2023 - 30-11-2027 Show more information EU-Programme-Call Horizon Europe HORIZON.2 Global Challenges and European Industrial Competitiveness HORIZON.2.1 Health HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine HORIZON-HLTH-2023-DISEASE-03 HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential